Related Experiment Video
Updated: May 21, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Rethinking cardiovascular risk: The emerging role of lipoprotein(a) screening
Victoria Clair1, Francis M Zirille2, Edward Gill2
1School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Screening for Lipoprotein(a) [Lp(a)], a key inherited cardiovascular disease risk factor, is crucial. Universal screening and advanced measurement methods can improve early detection and personalized prevention strategies for cardiovascular disease.
Area of Science:
- Cardiology
- Genetics
- Preventive Medicine
Background:
- Lipoprotein(a) [Lp(a)] is a significant, genetically inherited risk factor for cardiovascular disease (CVD).
- Elevated Lp(a) levels increase the risk of myocardial infarction and aortic valve stenosis by 2-3 fold.
- Limited integration of Lp(a) screening into practice is due to measurement inconsistencies and lack of targeted treatments.
Purpose of the Study:
- To clarify the role of Lp(a) in cardiovascular health.
- To examine evidence on optimal screening strategies, including who, when, and how to measure Lp(a).
- To support the integration of Lp(a) screening into routine cardiovascular risk assessment.
Main Methods:
- Review of current evidence on Lp(a) measurement and clinical relevance.
- Analysis of recommendations for screening across different populations.
- Evaluation of advancements in assay technology and emerging therapies.
Main Results:
- Universal, one-time screening for adults is recommended.
- Selective screening is advised for high-risk pediatric patients and those with familial hypercholesterolemia or chronic kidney disease.
- Advances in assay technology enable more precise Lp(a) measurement for improved risk stratification.
Conclusions:
- Lp(a) screening is essential for comprehensive cardiovascular risk assessment.
- Improved screening and emerging therapies can enhance early detection and personalized CVD prevention.
- Integrating Lp(a) assessment can benefit diverse patient populations in managing cardiovascular risk.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

